SAN CLEMENTE, Calif.--(BUSINESS WIRE)--A new clinical trial investigating the health benefits of açaí, the antioxidant and vitamin-rich berry, is adding to the emerging scientific evidence of the fruit’s ability to potentially reduce some metabolic risk factors associated with cardiovascular disease, diabetes and stroke. The latest study won top honors during the Scripps Center for Integrative Medicine on January 23 and revealed promising initial results for using Sambazon açaí to improve vascular health, lower fasting blood sugar levels, and lower bad cholesterol.
